Rhythm Pharmaceuticals, Inc.

US$112.28As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:RYTMHealthcare
Country USA
PE (Fwd) •••
TSR 9Y CAGR 17.82%
Div yield —
ROE (77.96%)
Biotechnology
Beta (5Y) 2.13
PE TTM —
TSR TTM (1.30%)
Mkt cap US$7.784B
ROIC (32.67%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$124
10.39%
131.41%
Hold 8|5|10|5|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.07
1.05
1.16
1.25
11.51%
5.38%
13.40%
21.80%
Revenue$B
1.069
1.110
1.145
1.131
11.32%
9.92%
8.81%
4.37%
Peers (US$7.784B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.272
(0.354)
(0.234)
EBIT/Intx
5.051
3.479
3.595
Own earn%
3.39
(118.06)
(101.55)
Sh yield%
15.53
20.33
19.95
Owners
Insiders/Inst%
9.73
20.28
Short interest%
4.98
SBC / revenue%
1.04
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
28–34
$1 testx
—
Incr. ROIC%
4